Vencanna Ventures Inc
VENI
Critical Reagent Processing Corp
CRPC
Sanu Gold Corp
SANU
Cannibble Food Tech Ltd
PLCN
Fineqia International Inc
FNQ
(FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 70.86%-465.71K | 113.58%28.77K | 92.82%-13.61K | 0.72%-294.06K | 79.25%-186.81K | -92.58%-1.6M | 18.65%-211.95K | -128.75%-189.59K | 61.24%-296.19K | -93.88%-900.18K |
Net income from continuing operations | 69.37%-828.33K | 75.58%-130.43K | 57.81%-148.33K | 5.13%-236.76K | 80.06%-312.81K | -112.02%-2.7M | 38.52%-534.08K | -227.21%-351.58K | -137.07%-249.57K | -15.68%-1.57M |
Operating gains losses | -85.63%133.12K | -164.01%-303.57K | --0 | --77.04K | --359.65K | 217.78%926.47K | 13,433.74%474.28K | 7,009,800.00%70.1K | ---- | ---- |
Depreciation and amortization | 20.84%63.01K | -58.25%15.75K | 199.94%15.75K | 199.96%15.75K | 302.92%15.75K | 177.40%52.14K | 702.96%37.73K | 11.75%5.25K | 11.72%5.25K | -16.79%3.91K |
Asset impairment expenditure | ---- | ---- | --0 | --1.05K | 30.67%4.9K | ---- | ---- | 159.81%3.04K | --0 | 53.06%3.75K |
Unrealized gains and losses of investment securities | ---- | ---- | -70.83%18.99K | 93.75%-26.09K | -145.24%-292.7K | ---- | ---- | 141.69%65.08K | -31.88%-417.42K | 59.94%647K |
Remuneration paid in stock | --0 | --0 | --0 | --0 | --0 | 58.38%210.54K | --0 | --0 | --0 | 92.90%210.54K |
Other non cashItems | -46.68%13.99K | -79.70%2.95K | -29.42%3.32K | -30.82%3.48K | 115.97%4.23K | -96.07%26.23K | 199.74%14.53K | -99.31%4.71K | 625.65%5.04K | 140.20%1.96K |
Change In working capital | 253.91%152.51K | 40.13%150.21K | 599.83%96.66K | -496.38%-128.73K | 117.31%34.37K | -255.55%-99.09K | 90.36%107.2K | 253.25%13.81K | 95.67%-21.59K | -138.54%-198.51K |
-Change in receivables | 45.20%9.84K | 252.90%547 | -18.87%12.42K | -122.44%-4.29K | 104.16%1.16K | 149.93%6.78K | 104.92%155 | 87.46%15.31K | -69.63%19.1K | 65.89%-27.79K |
-Change in prepaid assets | -82.20%4.37K | 88.99%-712 | -13.43%18.66K | -234.27%-19.17K | 216.91%5.6K | 128.13%24.57K | 82.90%-6.47K | 370.73%21.55K | 106.37%14.28K | 92.14%-4.79K |
-Change in payables and accrued expense | 206.03%138.3K | 32.48%150.38K | 384.58%65.59K | -91.51%-105.27K | 116.64%27.61K | -179.24%-130.43K | 16.66%113.51K | -5.92%-23.05K | 90.33%-54.97K | -125.24%-165.93K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 70.67%-465.71K | 114.26%28.77K | 92.82%-13.61K | 0.65%-294.26K | 79.27%-186.61K | -91.36%-1.59M | 22.55%-201.79K | -128.75%-189.59K | 61.24%-296.19K | -93.88%-900.18K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -53.22%219.18K | -54.52%218.51K | 0 | -2.07K | 376.74%2.74K | 634.25%468.54K | 4,728.56%480.44K | 88.56%-10.91K | 0 | -989 |
Net PPE purchase and sale | ---- | ---- | --0 | ---2.07K | 376.74%2.74K | ---- | ---- | 88.56%-10.91K | --0 | ---989 |
Net investment purchase and sale | -53.22%219.18K | ---- | ---- | ---- | ---- | --468.54K | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -53.22%219.18K | -54.52%218.51K | --0 | ---2.07K | 376.74%2.74K | 634.25%468.54K | 4,728.56%480.44K | 88.56%-10.91K | --0 | ---989 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 84.77%231.55K | 13.40%-237.43K | -88.29%4.48K | -18.36%303.1K | 1,709.66%161.4K | -88.23%125.32K | -4,465.85%-274.18K | 749.46%38.27K | -65.29%371.26K | -255.19%-10.03K |
Net issuance payments of debt | -12.87%-72.2K | -1.92%-18.25K | -0.97%-18.14K | 0.91%-17.91K | -78.58%-17.91K | -175.41%-63.97K | -198.18%-17.91K | -204.84%-17.96K | -219.05%-18.07K | -77.03%-10.03K |
Net common stock issuance | 47.72%307.25K | ---1 | --0 | ---- | ---- | -79.43%208K | --0 | --0 | ---- | ---- |
Net other financing activities | 81.30%-3.5K | 14.48%-219.18K | -59.78%22.62K | --13.76K | --179.31K | -124.45%-18.71K | ---256.27K | --56.23K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 84.77%231.55K | 13.40%-237.43K | -88.29%4.48K | -18.36%303.1K | 1,709.66%161.4K | -88.23%125.32K | -4,465.85%-274.18K | 749.46%38.27K | -65.29%371.26K | -255.19%-10.03K |
Net cash flow | ||||||||||
Beginning cash position | -95.68%45.44K | -61.87%20.6K | -86.25%29.73K | -83.88%22.77K | -95.68%45.44K | 16.22%1.05M | -95.87%54.04K | -71.20%216.27K | -68.46%141.2K | 16.22%1.05M |
Current changes in cash | 98.51%-14.97K | 214.64%9.86K | 94.37%-9.13K | -90.72%6.97K | 97.51%-22.67K | -785.48%-1.01M | 96.65%-8.6K | -129.07%-162.23K | -75.24%75.07K | -99.02%-911.2K |
End cash Position | -32.95%30.46K | -32.95%30.46K | -61.87%20.6K | -86.25%29.73K | -83.88%22.77K | -95.68%45.44K | -95.68%45.44K | -95.87%54.04K | -71.20%216.27K | -68.46%141.2K |
Free cash from | 70.67%-465.71K | 115.15%28.77K | 93.21%-13.61K | 0.65%-294.26K | 79.29%-186.61K | -73.07%-1.59M | 24.22%-189.89K | -135.55%-200.5K | 61.36%-296.19K | -94.09%-901.17K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.